Rama Krishna Kancha Selected Research

Pharmaceutical Preparations

5/2017

Computational analysis of ABL kinase mutations allows predicting drug sensitivity against selective kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rama Krishna Kancha Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2009
2	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2011
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Leukemia 11/2008

Drug/Important Bio-Agent (IBA)

7	Phosphotransferases (Kinase)IBA 01/2021 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2009
2	Imatinib Mesylate (Gleevec)FDA Link 05/2017 - 11/2008
1	Immune Checkpoint InhibitorsIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	osimertinibIBA 01/2019
1	mobocertinibIBA 01/2019
1	HM781-36BIBA 01/2019
1	AfatinibIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Pharmaceutical PreparationsIBA 05/2017
1	Estrogen ReceptorsIBA 01/2017
1	IsoxazolesIBA 01/2017
1	ColforsinIBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Lapatinib (GW572016)FDA Link 01/2011

Therapy/Procedure

1	Therapeutics 05/2017